Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

292.55

+9.05

(+3.19%)

At close: 04:00PM EDT

291.40

-1.15

(-0.39%)

After hours:

07:59PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Momentum

View all chart patterns

Performance Outlook

Previous Close	283.50
Open	286.26
Bid	291.49 x 800
Ask	292.90 x 1000
Day's Range	280.40 - 293.09
52 Week Range	176.36 - 293.17
Volume	4,268,979
Avg. Volume	1,772,575

Market Cap	74.821B
Beta (5Y Monthly)	0.55
PE Ratio (TTM)	30.88
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Undervalued

56% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for VRTX

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Vertex Pharmaceuticals Incorpor
Technical Assessment: Bearish in the Intermediate-TermLast week was (yet again) ugly for stocks, and the S&P 500 has now been down in 10 of the past 11 weeks (aka since the last week in March). The current move lower is much steeper than the decline from January to March 14. A steep decline leads to a high level of panic. But the faster prices fall, the sooner stocks can find an intermediate-term bottom. Both breadth and sentiment have been much worse during the current move lower than they were during the move off the highs earlier in the year.
Rating
Fair Value
Economic Moat
4 days agoArgus Research